Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Kini

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Indian Pediatrics|August 1, 1975
Comparison of pyrantel and tetramisole in ascariasisS Sood, A S Kini, J Master
Minerva Cardioangiologica|October 20, 2009
Coronary bifurcation lesionsS K Sharma, A M Mareş, A S Kini
The American Journal of Cardiology|December 1, 2001
A risk stratification scheme for selection of a glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention based on clinical and angiographic criteriaA S Kini, D Reich, C A Mitre, et al.
Cardiology|January 21, 2000
Angina pectoris in severe aortic stenosisG Dangas, S Khan, B H Curry, et al.
Clinical Pharmacology and Therapeutics|May 24, 2016
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivityS A Scott, J-P Collet, U Baber, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Indian Pediatrics|August 1, 1975
Comparison of pyrantel and tetramisole in ascariasisS Sood, A S Kini, J Master
Minerva Cardioangiologica|October 20, 2009
Coronary bifurcation lesionsS K Sharma, A M Mareş, A S Kini
The American Journal of Cardiology|December 1, 2001
A risk stratification scheme for selection of a glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention based on clinical and angiographic criteriaA S Kini, D Reich, C A Mitre, et al.
Cardiology|January 21, 2000
Angina pectoris in severe aortic stenosisG Dangas, S Khan, B H Curry, et al.
Clinical Pharmacology and Therapeutics|May 24, 2016
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivityS A Scott, J-P Collet, U Baber, et al.
Pageof 1